Rachelle W Johnson

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Topics

Breast Cancer Cells

Signaling Pathway

Long Noncoding Rna

Top Venues

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jeremy F Kane, Rachelle W Johnson
Re-Evaluating the Role of PTHrP in Breast Cancer. Cancers 15 (10) (2023)
Miranda E Clements, Lauren Holtslander, Joshua R Johnson, Rachelle W Johnson
Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy. JBMR plus 7 (3) (2023)
Miranda E Clements, Lauren Holtslander, Joshua R Johnson, Rachelle W Johnson
Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy. JBMR plus 7 (3) (2023)
Srilatha Swami, Joshua Johnson, Lawrence A Vecchi, Matthew Jundong Kim, Beate Lanske, Rachelle W Johnson, Joy Y Wu
Sex-Specific Differences in G s α-Mediated Signaling Downstream of PTH1R Activation by Abaloparatide in Bone. JBMR plus 6 (12) (2022)
Srilatha Swami, Joshua Johnson, Lawrence A Vecchi, Matthew Jundong Kim, Beate Lanske, Rachelle W Johnson, Joy Y Wu
Sex-Specific Differences in G s α-Mediated Signaling Downstream of PTH1R Activation by Abaloparatide in Bone. JBMR plus 6 (12) (2022)
Miranda E Clements, Lauren Holtslander, Courtney Edwards, Vera Todd, Samuel D R Dooyema, Kennady Bullock, Kensey Bergdorf, Cynthia A Zahnow, Roisin M Connolly, Rachelle W Johnson
HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer. Oncogene 40 (34) (2021)
Courtney M Edwards, Rachelle W Johnson
Targeting Histone Modifications in Bone and Lung Metastatic Cancers. Current osteoporosis reports 19 (3) (2021)
David B Vaught, Alyssa R Merkel, Conor C Lynch, James R Edwards, Mohammed Noor Tantawy, Timothy Hilliard, Shan Wang, Todd Peterson, Rachelle W Johnson, Julie A Sterling, Dana M Brantley-Sieders
EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease. JBMR plus 5 (4) (2021)
Rachelle W Johnson, Megan M Weivoda
Current Challenges for Early Career Researchers in Academic Research Careers: COVID-19 and Beyond. JBMR plus (2021)
Vera M Todd, Lawrence A Vecchi, Miranda E Clements, Katherine P Snow, Cayla D Ontko, Lauren E Himmel, Christopher Pinelli, Marjan Rafat, Rachelle W Johnson
Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner. Communications biology 4 (1) (2021)
Tolu Omokehinde, Alec Jotte, Rachelle W Johnson
gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2021)
Rachelle W Johnson
The Search For a Bone Metastasis Biomarker May Have a New Find: Circulating Osteocalcin-Positive Cells. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 35 (10) (2020)
Tolu Omokehinde, Rachelle W Johnson
GP130 Cytokines in Breast Cancer and Bone. Cancers 12 (2) (2020)
Vera Mayhew, Tolu Omokehinde, Rachelle W Johnson
Tumor dormancy in bone. Cancer reports (Hoboken, N.J.) 3 (1) (2019)
Miranda E Clements, Rachelle W Johnson
PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells. Oncogene 39 (6) (2019)